| Bioactivity | CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity. | ||||||||||||
| Invitro | CDD3506 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol[1]. | ||||||||||||
| Name | CDD3506 | ||||||||||||
| CAS | 197913-15-8 | ||||||||||||
| Formula | C22H19N3 | ||||||||||||
| Molar Mass | 325.41 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Method for increasing HDL cholesterol levels?using?heteroaromatic phenylmethanes. United States Patent 6103733 |